<rss version="2.0"><channel><title>VIVUS, Inc. - All News Releases</title><link>http://ir.vivus.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165</link><description /><language>en-us</language><generator>Shareholder.com RSS Feed</generator><item><title>VIVUS Announces Scientific Presentations</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=766457</link><pubDate>Wed, 22 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=766457</guid><description>VIVUS Announces Scientific Presentations</description></item><item><title>VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=765369</link><pubDate>Thu, 16 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=765369</guid><description>VIVUS Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes</description></item><item><title>VIVUS Announces Proposed Offering of Convertible Senior Notes</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=764862</link><pubDate>Wed, 15 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=764862</guid><description>VIVUS Announces Proposed Offering of Convertible Senior Notes</description></item><item><title>VIVUS Announces Scientific Presentations</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=764498</link><pubDate>Tue, 14 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=764498</guid><description>VIVUS Announces Scientific Presentations</description></item><item><title>VIVUS Mails Letter to Stockholders Providing Business Update</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=764129</link><pubDate>Mon, 13 May 2013 11:05:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=764129</guid><description>VIVUS Mails Letter to Stockholders Providing Business Update</description></item><item><title>VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=764120</link><pubDate>Mon, 13 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=764120</guid><description>VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors</description></item><item><title>VIVUS Reports First Quarter 2013 Financial Results</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=762940</link><pubDate>Wed, 08 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=762940</guid><description>VIVUS Reports First Quarter 2013 Financial Results</description></item><item><title>VIVUS Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca, to Serve as Senior Advisor</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=762486</link><pubDate>Tue, 07 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=762486</guid><description>VIVUS Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca, to Serve as Senior Advisor</description></item><item><title>VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=760832</link><pubDate>Wed, 01 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=760832</guid><description>VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call</description></item><item><title>New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity</title><link>http://ir.vivus.com/releasedetail.cfm?ReleaseID=760819</link><pubDate>Wed, 01 May 2013 04:00:00 GMT</pubDate><guid isPermaLink="true">http://ir.vivus.com/releasedetail.cfm?ReleaseID=760819</guid><description>New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity</description></item></channel></rss>